TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34074559

Group type: EXPERIMENTAL
Intervention: Lenvatinib plus pembrolizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cabozantinib plus nivolumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Axitinib plus pembrolizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ipilimumab plus nivolumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitors + ICI combinations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dual immunotherapy of ipilimumab and nivolumab
Number of subjects: 0
Study: 32527166

Group type: EXPERIMENTAL
Intervention: Family empowerment through educational interventions
Number of subjects: 33

Group type: COMPARATOR
Intervention: Nonstructural education
Number of subjects: 33
Study: 35578303

Group type: EXPERIMENTAL
Intervention: Prolonged requirement for insulin (PRI) on Day 5
Number of subjects: 476

Group type: COMPARATOR
Intervention: No prolonged requirement for insulin (non-PRI)
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Prolonged requirement for insulin (PRI) without glycemic control
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Prolonged requirement for insulin (PRI) with glycemic control
Number of subjects: 476
Study: 33156692

Group type: EXPERIMENTAL
Intervention: Foot core strengthening protocol (8-week training course focused on foot-ankle muscles)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 118
Study: 36252091

Group type: EXPERIMENTAL
Intervention: HF TENS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: LF TENS
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 60
Study: 33433786

Group type: EXPERIMENTAL
Intervention: Primary IORT (IORT at the time of lumpectomy)
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Unintended boost (primary IORT followed by whole-breast radiation)
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Delayed IORT (after lumpectomy)
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Intended boost
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Primary IORT with compliance to endocrine therapy
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Noncompliance with endocrine therapy
Number of subjects: 667
Study: 32375773

Group type: EXPERIMENTAL
Intervention: Counselling based on the WOMAN‐PRO II program
Number of subjects: 49

Group type: COMPARATOR
Intervention: Written information
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Counselling time
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Local recurrence
Number of subjects: 49
Study: 32012129

Group type: EXPERIMENTAL
Intervention: Azithromycin (500mg weekly)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Doxycycline (200mg weekly)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 35931968

Group type: EXPERIMENTAL
Intervention: Co-designed HIIT workouts for 8 weeks
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: HIIT Only group using co-designed HIIT workouts for 8 weeks
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group continuing regular HPE lessons
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Co-designed HIIT workouts
Number of subjects: 3
Study: 33017209

Group type: EXPERIMENTAL
Intervention: Radial Artery (RA)
Number of subjects: 619

Group type: COMPARATOR
Intervention: Right Internal Thoracic Artery (RITA)
Number of subjects: 619

Group type: COMPARATOR
Intervention: Saphenous Vein (SV)
Number of subjects: 619
Study: 35194663

Group type: EXPERIMENTAL
Intervention: ICG fluorescence cholangiography (ICG‐FC)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy
Number of subjects: 92
Study: 33676596

Group type: EXPERIMENTAL
Intervention: Listerine Cool Mint
Number of subjects: 343

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343

Group type: COMPARATOR
Intervention: Listerine Cool Mint and Placebo
Number of subjects: 343
Study: 35369700

Group type: EXPERIMENTAL
Intervention: Immediate ablation (within 2 months from shock delivery)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Continuation of standard therapy (control group)
Number of subjects: 517
Study: 32126840

Group type: EXPERIMENTAL
Intervention: Integrated personalized feedback intervention for anxiety sensitivity/hazardous drinking
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 130
Study: 32994239

Group type: EXPERIMENTAL
Intervention: Thymosin alpha 1
Number of subjects: 520

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520
Study: 32693046

Group type: EXPERIMENTAL
Intervention: Concomitant AF ablation
Number of subjects: 1675
Study: 35420393

Group type: EXPERIMENTAL
Intervention: Postoperative bilateral transversus abdominis plane block (TAPB) and nalbuphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nalbuphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 0
Study: 34168295

Group type: EXPERIMENTAL
Intervention: Diabetes nutrition education (two educational sessions of 30 min each)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 100
Study: 33098709

Group type: EXPERIMENTAL
Intervention: Active tDCS: 10 min of 2 mA
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham tDCS: 20 s of 2 mA
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: End-of-study guess
Number of subjects: 32
Study: 36131010

Group type: EXPERIMENTAL
Intervention: Allopurinol users
Number of subjects: 9252

Group type: COMPARATOR
Intervention: Non-users of allopurinol
Number of subjects: 9252
Study: 34910143

Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA-IM)
Number of subjects: 4062

Group type: COMPARATOR
Intervention: Copper intrauterine device (IUD)
Number of subjects: 4062

Group type: COMPARATOR
Intervention: Levonorgestrel (LNG) implant
Number of subjects: 4062

Group type: COMPARATOR
Intervention: DMPA-IM vs Copper IUD
Number of subjects: 4062

Group type: COMPARATOR
Intervention: DMPA-IM vs LNG implant
Number of subjects: 4062

Group type: COMPARATOR
Intervention: Copper IUD vs LNG implant
Number of subjects: 4062

Group type: EXPERIMENTAL
Intervention: HIV acquisition during follow-up
Number of subjects: 4062
Study: 35379621

Group type: EXPERIMENTAL
Intervention: Gatekeeper training intervention for vendors
Number of subjects: 2700000
Study: 34588210

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Blood Glucose Monitoring (BGM)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) continued
Number of subjects: 163
Study: 34273442

Group type: EXPERIMENTAL
Intervention: Prime & Bond Elect (PB) in self-etch (SE) mode
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal Adhesive (SBU) in etch-and-rinse (ER) mode
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal Adhesive (SBU) in self-etch (SE) mode
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Prime & Bond Elect (PB) in etch-and-rinse (ER) mode
Number of subjects: 54
Study: 34535409

Group type: EXPERIMENTAL
Intervention: Dry needling (DN) of the obliquus capitis inferior (OCI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham needling of the obliquus capitis inferior (OCI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (DN and sham)
Number of subjects: 40
Study: 35027415

Group type: EXPERIMENTAL
Intervention: Verum acupuncture group
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham acupuncture group
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups (verum and sham acupuncture)
Number of subjects: 72
Study: 33662102

Group type: EXPERIMENTAL
Intervention: Ivermectin, 300 µg/kg per day for 5 days
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 400
Study: 34412558

Group type: EXPERIMENTAL
Intervention: 10-week cognitive rehabilitation and lifestyle modifying intervention
Number of subjects: 57

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 57
Study: 33331183

Group type: EXPERIMENTAL
Intervention: Cladribine tablets 3.5 mg/kg
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study: 32935261

Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy focused on Emotional Development (PCIT-ED), n = 114
Number of subjects: 229

Group type: COMPARATOR
Intervention: Waitlist control condition, n = 115
Number of subjects: 229
Study: 35716852

Group type: EXPERIMENTAL
Intervention: Time‐restricted Feeding (TRF; restricting feeding window to 8 h/d)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Early Time‐restricted Feeding (eTRF; eating majority of kcals before 5pm)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Alternate Day Fasting (ADF; complete fasting every other day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Weight loss and energy intake across all diets (TRF, ADF, eTRF)
Number of subjects: 32
Study: 32056815

Group type: EXPERIMENTAL
Intervention: Biweekly yoga sessions
Number of subjects: 79

Group type: COMPARATOR
Intervention: No yoga (control group)
Number of subjects: 79
Study: 36448959

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 2400 mg/day for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 60
Study: 34620311

Group type: EXPERIMENTAL
Intervention: 10% glucose for supported mineral carrier (subgroup A)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Total parenteral nutrition (subgroup B)
Number of subjects: 39
Study: 36040789

Group type: EXPERIMENTAL
Intervention: iCanCope intervention
Number of subjects: 56
Study: 35272971

Group type: EXPERIMENTAL
Intervention: Closed-loop insulin delivery (Cambridge hybrid closed-loop algorithm)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Usual care with insulin pump therapy (control group)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Closed-loop insulin delivery (FlorenceM configuration)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Closed-loop insulin delivery (CamAPS FX configuration)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Closed-loop group
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 133
Study: 33082016

Group type: EXPERIMENTAL
Intervention: LSD 5 mcg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LSD 10 mcg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LSD 20 mcg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 34758080

Group type: EXPERIMENTAL
Intervention: Amiselimod 0.4 mg
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 34830743

Group type: EXPERIMENTAL
Intervention: Violet light-transmitting eyeglasses (VL glasses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional eyeglasses (placebo glasses)
Number of subjects: 0
Study: 33010985

Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36164731

Group type: EXPERIMENTAL
Intervention: Novel rehabilitation intervention
Number of subjects: 349
Study: 33236763

Group type: EXPERIMENTAL
Intervention: Histologic remission
Number of subjects: 215

Group type: COMPARATOR
Intervention: Persistent histologic activity
Number of subjects: 215
Study: 34387014

Group type: EXPERIMENTAL
Intervention: New electron microscope with updated digital camera and new software for imaging and analysis
Number of subjects: 14

Group type: COMPARATOR
Intervention: Original images measured using a separate software method
Number of subjects: 14

Group type: COMPARATOR
Intervention: Original measurements of GBMs obtained on the laboratory's previous EM
Number of subjects: 14
Study: 32856251

Group type: EXPERIMENTAL
Intervention: Zinc threonine chelate (80 mg zinc per kg feed)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Zinc threonine chelate (80 and 120 mg zinc per kg feed)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Zinc threonine chelate
Number of subjects: 256

Group type: COMPARATOR
Intervention: Control treatment (no zinc supplementation)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Zinc sulfate (40, 80, and 120 mg zinc per kg feed)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Commercial chelate (Bioplex Zn®) (40 mg zinc per kg feed)
Number of subjects: 256
Study: 33930380

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally followed by misoprostol 800 mcg vaginally 24 hours later
Number of subjects: 291

Group type: COMPARATOR
Intervention: Misoprostol alone
Number of subjects: 291
Study: 35121566

Group type: EXPERIMENTAL
Intervention: Young Person's Face IT (self-guided web-based psychosocial intervention)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 189
Study: 34030768

Group type: EXPERIMENTAL
Intervention: Silymarin (150 mg, three times daily for 7 days)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (FOLFIRI plus bevacizumab without silymarin)
Number of subjects: 70
Study: 35426929

Group type: EXPERIMENTAL
Intervention: Multiorgan Focused Clinical Ultrasonography
Number of subjects: 0
Study: 34962506

Group type: EXPERIMENTAL
Intervention: Clinical decision support tool for discontinuing overnight vital sign checks
Number of subjects: 1699

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1699
Study: 33513929

Group type: EXPERIMENTAL
Intervention: 548 mg/day of polyphenols and 2 g/day of L-citrulline for 6 weeks
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 73
Study: 32719307

Group type: EXPERIMENTAL
Intervention: LCP-tacrolimus
Number of subjects: 496

Group type: COMPARATOR
Intervention: Immediate-release tacrolimus
Number of subjects: 496
Study: 35996282

Group type: EXPERIMENTAL
Intervention: Levofloxacin plus an optimized background regimen
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 255
Study: 36079750

Group type: EXPERIMENTAL
Intervention: Novel Amino Acid mix (TRG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo mix (PLG)
Number of subjects: 22
Study: 33658545

Group type: EXPERIMENTAL
Intervention: Lowest BPV group
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Highest BPV group
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Higher BPV
Number of subjects: 746

Group type: COMPARATOR
Intervention: Mean systolic BP
Number of subjects: 746
Study: 32398040

Group type: EXPERIMENTAL
Intervention: MDT and 6 months of ADT
Number of subjects: 0

Group type: COMPARATOR
Intervention: WPRT added to MDT and 6 months of ADT
Number of subjects: 0
Study: 33297668

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induction therapy with ASCT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Induction therapy without ASCT
Number of subjects: 0
Study: 32914728

Group type: EXPERIMENTAL
Intervention: Non-functioning adrenal incidentalomas (NFAI) group
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: NFAI group with CAC score <100
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: NFAI group with CAC score ?100
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study: 32663102

Group type: EXPERIMENTAL
Intervention: Indacaterol 110 µg/glycopyrronium 50 µg once daily (OD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Tiotropium 50 µg OD
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium
Number of subjects: 50
Study: 36460536

Group type: EXPERIMENTAL
Intervention: ERUCoV-VAC 3 μg
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: ERUCoV-VAC 6 μg
Number of subjects: 294

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 294
Study: 33627077

Group type: EXPERIMENTAL
Intervention: TENS therapy during the first stage of labor
Number of subjects: 326

Group type: COMPARATOR
Intervention: Routine obstetric care (control group)
Number of subjects: 326
Study: 32533013

Group type: EXPERIMENTAL
Intervention: Local tissue electrical parameters (TEPs) measured during the first week of radiation therapy.
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Local impedance module and resistance (TEPs)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Radiation therapy (RT)
Number of subjects: 135
Study: 35595661

Group type: EXPERIMENTAL
Intervention: TAK-214 vaccine (15/15, 15/50, 50/50, or 50/150 μg of GI.1/GII.4c genotype VLPs with 0.5 mg Al(OH)3)
Number of subjects: 240
Study: 33476659

Group type: EXPERIMENTAL
Intervention: Mifepristone followed by misoprostol (200 mg oral mifepristone followed by 800 mcg vaginal misoprostol)
Number of subjects: 139
Study: 34939823

Group type: EXPERIMENTAL
Intervention: Exposure to mother's scent (n = 52)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (n = 52)
Number of subjects: 104
Study: 33870612

Group type: EXPERIMENTAL
Intervention: Mobile phone text messaging intervention targeting dietary behaviours
Number of subjects: 25
Study: 32234296

Group type: EXPERIMENTAL
Intervention: Intervention phase cleaning of bedroom FTPs
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control phase cleaning of bathroom FTPs
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Intervention phase cleaning of bathroom FTPs
Number of subjects: 300
Study: 33687525

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1422

Group type: EXPERIMENTAL
Intervention: Active drug (JAK inhibitor)
Number of subjects: 1422
Study: 33554776

Group type: EXPERIMENTAL
Intervention: Responsible Behavior with Younger Children (RBYC) program
Number of subjects: 0
Study: 32568092

Group type: EXPERIMENTAL
Intervention: Intervention group received short instant messages through an app over 4 months.
Number of subjects: 640

Group type: COMPARATOR
Intervention: Control group received standard family planning information and control messages through the same app.
Number of subjects: 640
Study: 36455430

Group type: EXPERIMENTAL
Intervention: Phone coaching
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Text message coaching
Number of subjects: 230

Group type: COMPARATOR
Intervention: No support control group
Number of subjects: 230
Study: 33578362

Group type: EXPERIMENTAL
Intervention: Out-of-pocket costs for hospitalization
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Catastrophic health expenditures
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Reduction of length of stay, elimination of the need for next of kin, provision of healthcare services out of hospitals
Number of subjects: 800
Study: 35596620

Group type: EXPERIMENTAL
Intervention: Family-based adherence intervention
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: High adherence (≥95%)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Socioeconomic status (SES), child race, family functioning, parent distress
Number of subjects: 200
Study: 35725922

Group type: EXPERIMENTAL
Intervention: Licogliflozin 150 mg
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Licogliflozin 30 mg
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 33463868

Group type: EXPERIMENTAL
Intervention: Nutritional Risk Screening (NRS 2002) by nursing students
Number of subjects: 508
Study: 35943499

Group type: EXPERIMENTAL
Intervention: Navigational surgical template in vestibuloplasty protocol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Classical technology in vestibuloplasty
Number of subjects: 48
Study: 34779225

Group type: EXPERIMENTAL
Intervention: Manual thrombus aspiration (TA) during primary PCI
Number of subjects: 9147

Group type: COMPARATOR
Intervention: Non-thrombus aspiration (non-TA) during primary PCI
Number of subjects: 9147
Study: 32663919

Group type: EXPERIMENTAL
Intervention: Professionally applied topical fluoride (DHSU‐PATF)
Number of subjects: 1404
Study: 36106611

Group type: EXPERIMENTAL
Intervention: Proteus Discover adherence system with TDF/FTC
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard-of-care TDF/FTC
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Proteus Discover adherence system
Number of subjects: 100
Study: 33980288

Group type: EXPERIMENTAL
Intervention: Basic Acupuncture (BA)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Needle Duration (ND)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 32
Study: 32590371

Group type: EXPERIMENTAL
Intervention: Asymmetric anodic‐first (AA) stimulation
Number of subjects: 3

Group type: COMPARATOR
Intervention: Standard symmetric cathodic‐first (SC) pulse
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Asymmetric stimuli with large duration ratios (≥20)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Asymmetric cathodic‐first (AC) stimuli
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Asymmetric anodic‐first (AA) stimulation with small duration ratios (≤5) and long IPGs (≥2 ms)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Symmetric anodic‐first (SA) stimulation
Number of subjects: 3
Study: 35759319

Group type: EXPERIMENTAL
Intervention: Theory-based educational intervention and WhatsApp follow-up; delivered in two stages: face-to-face and WhatsApp follow-up.
Number of subjects: 401

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 401
Study: 33157498

Group type: EXPERIMENTAL
Intervention: Copper-oxide impregnated sanitary towel (study group)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Non-copper sanitary towel (control group)
Number of subjects: 450
Study: 32332638

Group type: EXPERIMENTAL
Intervention: Jade moxibustion
Number of subjects: 148

Group type: COMPARATOR
Intervention: Traditional moxibustion
Number of subjects: 148
Study: 33593789

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including nutrition optimization, parenting program with cognitive-behavioral therapy, lifestyle behavior change, and reduction of environmental pollution.
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 6000
Study: 33039655

Group type: EXPERIMENTAL
Intervention: Fit from Home (FFH) campaign
Number of subjects: 8942

Group type: COMPARATOR
Intervention: COVID-19 pandemic
Number of subjects: 8942
Study: 35262602

Group type: EXPERIMENTAL
Intervention: Educational booklet
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual service care
Number of subjects: 150